The new immunosuppressive drugs for renal transplantation: inhibitors of the mammalian target of rapamycin (mTOR) and anti-thymocyte globulin (Thymoglobulin)
Nakagawa, Y.; Ikeda, M.; Tasaki, M.; Saito, K.; Takahashi, K.
Nihon Jinzo Gakkai Shi 55(2): 112-118
2013
ISSN/ISBN: 0385-2385 PMID: 23631297 Document Number: 669701
Document emailed within 1 workday
Related Documents
Widmer, U.; Frei, D.; Keusch, G.; Burger, H.R.; Largiader, F.; Binswanger, U. 1988: OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine a Transplantation Proceedings 20(5 Suppl 6: 90-95Wang, J.-d.; Wang, Q.-s.; Bai, Y.-z.; Kou, D.-q.; Li, X.-r.; Chen, L.; Li, R. 2013: Effects of mammalian-target-of-rapamycin pathway on lapatinib resistance in breast cancer MDA-MB-231 cells Zhonghua Yi Xue Za Zhi 93(24): 1915-1917
Pan, T.-F.; Liang, C.-Z.; Chen, X.-G.; Fan, S. 2013: Mammalian target of rapamycin regulates androgen receptor and Akt phosphorylation in prostate cancer 22RV1 cells Zhonghua Nan Ke Xue 19(12): 1068-1071
Basić-Jukić, N.; Kes, P. 2011: Novel immunosuppressive drugs in renal transplantation Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 65(4): 361-364
Liu, Y.; Guo, Y.-f. 2008: Expression of mammalian target of rapamycin and p70 S6 kinase in rabbit periodontal tissues remodeling during orthodontic tooth movement Hua Xi Kou Qiang Yi Xue Za Zhi 26(6): 580
Hudes, G.R. 2007: MTOR as a target for therapy of renal cancer Clinical Advances in Hematology and Oncology: H&o 5(10): 772-774
Gilbert, C. 1984: Clinical uses of anti-thymocyte globulin (ATGAM), Part Ii North Carolina Medical Journal 45(12): 773-775
Diethelm, A.G.; Chambers, L.M.; Balch, C.M.; Phillips, S.J. 1976: Preparation and immunosuppressive potency of equine anti-human thymocyte membrane IgG Postgraduate Medical Journal 52(5 Suppl): 55-58
Fisher, R.I.; Silver, B.A.; Vanhaelen, C.P.; Jaffe, E.S.; Cossman, J. 1982: Objective regressions of T- and B-cell lymphomas in patients following treatment with anti-thymocyte globulin Cancer Research 42(6): 2465-2469
Thomas, J.; Millington, M.; Volk, M.; Thomas, F.; Hume, D. 1974: Rabbit anti-human thymocyte globulin (RAHTG): in vitro and in vivo testing Transplantation Proceedings 6(4): 395-398
Brocard, J.F.; Farahmand, H.; Fassi, S.; Plaisant, B.; Fries, E.; Cantarovich, M.; Bismuth, A.; Lambert, T.; Hiesse, C.; Lantz, O. 1989: Attempt at depletion of anti-HLA antibodies in sensitized patients awaiting transplantation using extracorporeal immunoadsorption, polyclonal IgG, and immunosuppressive drugs Transplantation Proceedings 21(1 Part 1): 733-734
Prager, M.D.; Gregg, D.E.; Walter, M.C. 1978: Effect of sera of patients with genitourinary tract cancers on transformation of lymphocytes stimulated with anti-thymocyte globulin National Cancer Institute Monograph 49: 127-130
Sun, Z.; Wen, Y.; Mao, Q.; Hu, L.; Li, H.; Sun, Z.; Wang, D. 2010: Adenosine-triphosphate promoting repair of spinal cord injury by activating mammalian target of rapamycin/signal transducers and activators of transcription 3 signal pathway in rats Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(2): 165-171
Valderrábano, F.; Anaya, F.; Robles, N.R.; Jofré, R. 1988: Sequential therapy with anti-thymocyte globulin and cyclosporine a in oligoanuric high-risk cadaveric kidney graft recipients Transplantation Proceedings 20(5 Suppl 6: 75-78
Ma, Q.; Chang, Z.; Wang, W.; Wang, B. 2015: Rapamycin-Mediated mTOR Inhibition Reverses Drug Resistance to Adriamycin in Colon Cancer Cells Hepato-Gastroenterology 62(140): 880-886
Costanzo-Nordin, M.R.; O'Sullivan, E.J.; Johnson, M.R.; Winters, G.L.; Pifarre, R.; Radvany, R.; Zucker, M.J.; Scanlon, P.J.; Robinson, J.A. 1990: Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation Journal of Heart Transplantation 9(3 Part 2): 306-315
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Chen, C.-y.; Sun, Y.-N.ü; Yang, Z.-c.; Cai, Z.-l. 2008: Effects of mTOR inhibitor rapamycin on Smad 3 protein and collagen type i expression in rat myocardial fibroblasts infected with coxsackie virus B 3 Zhonghua Xin Xue Guan Bing Za Zhi 36(2): 156-160
Pötsch, S.; Drechsler, H.; Liermann, B.; Gräslund, A.; Lassmann, G. 1994: P-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs Molecular Pharmacology 45(4): 792-796
Levitzki, A. 1996: SRC as a target for anti-cancer drugs Anti-Cancer Drug Design 11(3): 175-182